This study unravelled the intermolecular interaction of iron uptake at the blood-brain barrier, and provided potential therapeutic targets, such as astrocyte hepcidin and microvascular endothelial FPN1, for the treatment of brain iron dysregulation and its related neurological diseases. The gene discussed is HAMP; the disease is nervous system disorder.